GGrantIndex
← Search

SAFETY OF EB1089 IN EARLY RECURRENT PROSTATE CANCER

$134,676M01FY2001RRNIH

Stanford University, Stanford CA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →